Distinct Pattern of Inflammatory Enzyme Activities in Human Ovarian Cancer and Benign Myoma
DOI:
https://doi.org/10.6000/1927-7229.2012.01.01.19Keywords:
NAG (N-acetylglucosaminidase), MPO (Myeloperoxidase), Neutrophils, Macrophages, Enzymes, inflammatory response, Ovarian cancer, inflammation, myoma, pelvic surgeryAbstract
Objective: Inflammatory cells and their products are significant components of malignancies. This study was performed to determine the activity of inflammatory enzymes myeloperoxidase (MPO) and N-acetylglucosaminidase (NAG) in ascitic fluid, sera or peritoneal lavage fluid from patients with epithelial ovarian cancer (EOC). Methods: Eighteen patients age ranging from 25 to 79 years (54.6±2.9 years) with epithelial ovarian cancer submitted to surgical treatment (EOC group) and 17 patients with uterine myoma (Myoma group) submitted to abdominal hysterectomy (control group) were prospectively studied. MPO and NAG activities were evaluated colorimetrically in sera, ascites or peritoneal lavage fluid obtained from the patients at the time of laparotomy. Results: In a total of 18 EOC, there were stage I in 1 case (5.5%), II in 3 (16.7%), III in 11 (61.1%) and IV in 3 cases (16.7%). MPO activity in sera of EOC was higher than in the ascitic fluid from the same patients. Conversely, MPO activity was similar in sera from both EOC and myoma-bearing patients. Comparison between NAG activities in sera from both groups showed much higher values in the OEC patients. Furthermore, inflammatory enzyme activities were overall associated with the stage of the disease. Conclusions: Our results show that inflammation has been positively correlated with cancer and that the pattern of a systemic inflammatory response induced by EOC differs quantitatively from that of a typical benign pelvic condition. The most important limitation lies in the fact that the number of patients and controls was relatively small. Further studies with a larger number of patients and longer follow-up are necessary to assess the accuracy of the diagnostic and prognostic impact of these results.
References
Look K. Epidemiology, etiology, and screening of ovarian cancer. In: Rubin SC, Sutton GP, Eds., Ovarian cancer (2nd ed.), Lippincott Williams & Wilkins, Philadelphia, Pennsylvania 2001; pp. 167-80.
Heintz AP, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. Int J Gynaecol Obstet 2003; 83(Suppl 1): 135-66. http://dx.doi.org/10.1016/S0020-7292(03)90118-4
Cannistra SA. Cancer of ovary. N Engl J Med 1993; 329 (21): 1550-559. http://dx.doi.org/10.1056/NEJM199311183292108
Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 253-64. http://dx.doi.org/10.1016/0027-5107(94)90245-3
Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role of inflammatory disease and progression to cancer. Biochem J 1996; 313: 17-29.
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-45. http://dx.doi.org/10.1016/S0140-6736(00)04046-0
Coussens LM, Werb Z. Inflammatory cells and cancer: think different! J Exp Med 2001; 19; 193(6): 727-40.
Lewis EC, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66(2): 605-612. http://dx.doi.org/10.1158/0008-5472.CAN-05-4005
Negus RP, Stamp GM, Hadley J, Balkwill FR. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 1997; 150(5): 1723-34.
Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001; 193: 727: 40.
Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Bio 2005; 77: 598-25. http://dx.doi.org/10.1189/jlb.1204697
Trush MA, Seed JL, Kensler TW. Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer. Proc Natl Acad Sci USA 1985; 82(15): 5194-8. http://dx.doi.org/10.1073/pnas.82.15.5194
Van Rensburg CEJ, Van Staden AM, Anderson R, Van Rensburg EJ, Hypochlorous acid potentiates hydrogen peroxide-mediated DNA-strand breaks in human mononuclear leucocytes. Mutat Res 1992; 265: 255-61. http://dx.doi.org/10.1016/0027-5107(92)90054-6
Woynarowska B, Wikiel H, Bernacki RJ. Human ovarian carcinoma -N-acethylglucosaminidase isoenzymes and their role in extracellular matrix degradation. Cancer Res 1989; 49: 5598-604.
Gil Martin E, Gil-Seijo S, Nieto-Novoa C, Fernandez-Briera A. Elevation of acid glycosidase activities in thyroid and gastric tumors. Int J Biochem Cell Biol 1996; 28(6): 651-57. http://dx.doi.org/10.1016/1357-2725(96)00010-6
Belo AV, Barcelos LS, Teixeira MM, Ferreira MAND, Andrade SP. Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in mice. Cancer Invest 2004; 22: 723-29. http://dx.doi.org/10.1081/CNV-200032992
Severini G, Aliberti M. Serum N-acetyl-beta-glucosaminidase activity in breast cancer. Cancer Biochem Biophys 1994; 14: 87-92.
Luqmani Y, Temmim L, Memon A, et al. Measurement of serumN-acetyl glucosaminidase activity in patients with breast cancer. Acta Oncol 1999; 38: 649-53. http://dx.doi.org/10.1080/028418699431267
Song M, Santanam M. Increased myeloperoxidase and lipid peroxidise-modified protein in gynaecological malignancies. Antioxid Redox Signal 2001; 3(6): 1139-46. http://dx.doi.org/10.1089/152308601317203648
Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78(3): 206-9. http://dx.doi.org/10.1111/1523-1747.ep12506462
Baley PJ. Sponge implants as models. Methods Enzymol 1988; 162: 327-34. http://dx.doi.org/10.1016/0076-6879(88)62087-8
Freedman RS, Deavers M, Liu J, Wang E. Peritoneal inflammation-A microenvironment for epithelial ovarian cancer (EOC). J Transl Med 2004; 2: 1-10. http://dx.doi.org/10.1186/1479-5876-2-23
Wang X, Deavers M, Patenia R, et al. Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease. J Transl Med 2006; 6(4): 30.
Olsson I, Olofsson T, Ohlsson K, Gustavsson A. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia. Scand J Haematol 1979; 22(5): 397-06. http://dx.doi.org/10.1111/j.1600-0609.1979.tb00437.x
Dobrossy L, Pavelic Z, Vaughan M, Porter N, Bernacki RJ. Elevation of lysosomal enzymes in primary lung tumor correlated with the initiation of metastasis. Cancer Res 1980; 40: 3281-85.
Robinson-Smith TM, Isaacsohn I, Mercer CA, et al. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res 2007; 67: 5708-16. http://dx.doi.org/10.1158/0008-5472.CAN-06-4375
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- T.G. Shrihari, Inflammation and Cancer: Critical View , Journal of Analytical Oncology: Vol. 7 No. 2 (2018)
- Tommaso Cai, Gabriella Nesi, Sandra Mazzoli, Francesca Meacci, Galliano Tinacci, Cesare Selli , Riccardo Bartoletti , Inflammation and Urothelial Bladder Cancer: What we Need to Known? (Review) , Journal of Analytical Oncology: Vol. 4 No. 2 (2015)
- T.G. Shrihari, Chronic Inflammatory Mediators Induced Malignant Changes in Inflammatory Microenvironment of Oral Potentialy Malignant Conditions - An Emerging Concept , Journal of Analytical Oncology: Vol. 7 No. 4 (2018)
- T.G. Shrihari, Chronic Inflammatory Mediators Induced Malignant Changes in Tumor Microenvironment of Oral Squamous Cell Carcinoma-New Insight , Journal of Analytical Oncology: Vol. 7 No. 4 (2018)
- Miricescu Daniela, Totan Alexandra, Calenic Bogdan, Parlatescu Ioanina, Mohora Maria, Greabu Maria, Salivary Diagnosis: Detection of Several Intracellular Enzymes in Patients with Oral Lichen Planus , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- T.G. Shrihari, Myeloid Derived Suppressor Cells in Oral Cancer: An Emerging Concept , Journal of Analytical Oncology: Vol. 7 No. 2 (2018)
- Kazuya Kuraoka, Kiyomi Taniyama, Miho Tanaka, Yukari Nakagawa, Naoko Yasumura, Tamaki Toda, Mikie Shitaune, Akihisa Saito, Junichi Sakane, Yoko Kodama, Toshinao Nishimura, Nao Morii, Hirotoshi Takahashi , Hiroyasu Yamashiro , Auto-Analysis for Ki-67 Indices of Breast Cancer Using Specified Computer Software and a Virtual Microscopy , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Paola Castro-Garcia, Carmen Gil-Gas, Paloma Honrubia-Gómez, Carmen Belen Alvarez-Simón, Jesús-José Ferré-Fernández, Francisco Sánchez-Sánchez, Jose Luis Sánchez-Sánchez, Jose Mª Garcia-Bueno, Sebastiá Sabater, Guadalupe Aparicio, Luis Miguel Antón-Aparicio, Carmen Ramírez-Castillejo, C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Novoa Vargas Arturo, Neoadyuvant Hormonotherpy for Posmenopausics Women with Locallity Advanced Breast Cancer , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Joseph E. Udosen, John A. Ashindoitiang, Victor I.C. Nwagbara, Theophilus I. Ugbem, Joseph S. Ukam, Maurice E. Asuquo, Concurrent Plasma Cell Mastitis and Metastatic Breast Cancer a Rare Presentation of a Bilateral Disease: Case Report and Literature Review , Journal of Analytical Oncology: Vol. 13 (2024)
You may also start an advanced similarity search for this article.